CLAYRAS/Terms & Disclaimer

Website terms and pharma API disclaimer.

This page explains the terms of using CLAYRAS website information and the important disclaimers applicable to pharmaceutical API export, sourcing, documentation and regulated product discussions.

Last updated: May 2026
Important commercial noticeInformation on this website is provided for B2B pharmaceutical inquiry, export coordination and documentation discussion purposes only. Product-specific availability, suitability and documentation are reviewed according to buyer requirements.

1. Website Use

By using this website, you agree to use the information for lawful business inquiry and communication purposes only. The website is intended for pharmaceutical manufacturers, API importers, distributors, wholesalers, regulatory teams and procurement professionals.

2. Information Disclaimer

Product information, categories, CAS references, document context and API portfolio details are provided for initial buyer discussion and should not be treated as final commercial, regulatory or technical approval.

CLAYRAS aims to keep information accurate and updated, but product status, grade, packaging, documentation, source context, shipment feasibility and commercial terms may change over time.

3. No Medical Advice

The website does not provide medical, clinical, therapeutic or patient-use advice. API references are intended for qualified B2B pharmaceutical and regulatory professionals.

4. Product Availability and Documentation

Product availability, COA, MSDS, TDS, specification, DMF, CEP, GMP/GLP context, Written Confirmation, sample availability, MOQ, pricing and lead time are reviewed product-wise and source-wise.

  • Listing a product on the website does not guarantee immediate stock availability.
  • Document availability may vary by product, manufacturer, batch, grade and destination market.
  • Final commercial discussion depends on buyer requirement, quantity, documentation expectation and export feasibility.

5. Regulated API Disclaimer

Regulated product noticeCertain APIs, including hormonal, steroidal or market-regulated products, may require additional documentation, import permissions, end-use declarations, regulatory review or destination-country approvals before commercial movement.

CLAYRAS may request additional buyer information or documentation before proceeding with inquiries involving sensitive, restricted or regulated API categories.

6. Buyer Responsibility

Buyers are responsible for verifying local import requirements, product registration needs, customs rules, end-use restrictions and applicable regulatory approvals in their destination country.

  • Buyer must confirm whether the API can be imported and used in their market.
  • Buyer must ensure compliance with applicable pharmaceutical, customs and regulatory laws.
  • Buyer should review final COA, specification, regulatory documents and commercial terms before purchase decisions.

7. Third-Party Sources and Documents

Where applicable, CLAYRAS may coordinate with manufacturer-side or source-side documentation. Third-party certificates, declarations or documents remain subject to issuing party validity, scope and verification.

8. Limitation of Liability

CLAYRAS is not liable for business decisions made solely based on general website information. Product-specific decisions should be based on confirmed documentation, commercial communication, regulatory review and written agreement.

9. Changes to These Terms

CLAYRAS may update these Terms & Disclaimer from time to time. Continued use of the website after updates indicates acceptance of the revised terms.

10. Contact

For product-specific API inquiry, documentation discussion or export coordination questions, contact CLAYRAS through the official inquiry form or contact details.

Need product-specific clarification?

Share your API name, CAS number, grade, quantity and destination country for structured review.

Submit API Inquiry